Evaluation of Endothelial Dysfunction Using the Flow Mediated Dilation Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT06347029

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Brugmann University Hospital (from the registry)
Registry
  • NCT NCT06347029
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06347029. Non-randomized; no masking; primary purpose basic science. Start 2023-10-17 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
Condition
Chronic Renal Failure
Intervention (Procedure)
Urine sampling
Intervention (Procedure)
Blood sampling
Intervention (Device)
Flow mediated dilatation test
Lead sponsor
Brugmann University Hospital (class: other)

Record details

Record id
cardio:ct-nct06347029
Content hash
1659c14d3aec41a7ce2097afc9fe58f70ee0f1559b5237b0444495f30823e53b